Baynes Roy D. bought TVTX

May 1, 2026 · Form 4 insider transaction

Baynes Roy D. bought 9,750 shares of Travere Therapeutics, Inc. at $6.82 per share, a transaction worth $66.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.